Benjamin Verret
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 6
- Cancer-related Molecular Pathways 5
-
- Sarcoma Diagnosis and Treatment 17
- Advanced Breast Cancer Therapies 6
- Co-authors
- Alexis Laurent (2 shared papers)Camilla Pilati (2 shared papers)Andrea Franconi (2 shared papers)Charles Paul Balabaud (2 shared papers)Jean‐Charles Nault (2 shared papers)Éric Letouzé (2 shared papers)Gabrielle Couchy (2 shared papers)Julien Caldéraro (2 shared papers)
- Journals
- Annals of Oncology (10 papers)European Journal of Cancer (6 papers)The Lancet Oncology (3 papers)ESMO Open (3 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Benjamin Verret
58 papers receiving 1.6k citations
Benjamin Verret's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 437
- Oncology 590
- Pulmonary and Respiratory Medicine 441
- Pathology and Forensic Medicine 163
- Genetics 262
Countries citing papers authored by Benjamin Verret
This map shows the geographic impact of Benjamin Verret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Verret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Verret more than expected).
Fields of papers citing papers by Benjamin Verret
This network shows the impact of papers produced by Benjamin Verret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Verret. The network helps show where Benjamin Verret may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Verret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic characterization of metastatic breast cancers Hit paper breakdown → | 2019 | 529 |
| 2 | Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas Hit paper breakdown → | 2015 | 408 |
| 3 | 2021 | 127 | |
| 4 | 2018 | 113 | |
| 5 | 2023 | 56 | |
| 6 | 2024 | 39 | |
| 7 | 2021 | 38 | |
| 8 | 2018 | 24 | |
| 9 | 2025 | 22 | |
| 10 | 2018 | 19 | |
| 11 | 2017 | 16 | |
| 12 | 2023 | 15 | |
| 13 | 2021 | 14 | |
| 14 | 2024 | 14 | |
| 15 | 2016 | 13 | |
| 16 | 2024 | 12 | |
| 17 | 2024 | 12 | |
| 18 | 2025 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2022 | 11 |
About Benjamin Verret
Benjamin Verret is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Gastroenterology and Rheumatology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cardiac tumors and thrombi (5 papers), Cancer-related Molecular Pathways (5 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Neurofibromatosis and Schwannoma Cases (5 papers). The work is most often cited by research in Cancer Research (437 citations), Oncology (590 citations), Pulmonary and Respiratory Medicine (441 citations), Pathology and Forensic Medicine (163 citations) and Genetics (262 citations). Benjamin Verret has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Alexis Laurent, Camilla Pilati, Andrea Franconi, Charles Paul Balabaud, Jean‐Charles Nault, Éric Letouzé, Gabrielle Couchy, Julien Caldéraro, Maxime Mallet and Jessica Zucman‐Rossi. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, The Lancet Oncology, ESMO Open and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.